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Abstract 
Background: The activation of polymorphonuclear neutrophils (PMNs) plays an important role in sepsis. Previously, 
we showed that ATP release and feedback via ATP receptors are essential for PMN activation; however, the dynamics 
remain poorly understood. Two new fluorescent chemosensors, PMAP-1 and MitoAP-1, were developed to detect 
ATP in the plasma membrane and mitochondria of living cells, respectively. In this study, we aimed to evaluate ATP 
localization using these chemosensors in PMNs of sepsis patients.
Methods: Live PMNs isolated from 16 sepsis patients and healthy controls (HCs) were stained with these chemosen-
sors and observed by confocal microscopy, and their mean fluorescence intensities (MFIs) were evaluated using flow 
cytometry. CD11b expression in PMNs was also evaluated.
Results: The MFIs of PMAP-1 and MitoAP-1 and CD11b expression in PMNs from sepsis patients on days 0–1 were 
significantly higher than those of HCs. The MFI of PMAP-1 and CD11b expression on days 3–4 decreased significantly 
compared to those observed at days 0–1, whereas MitoAP-1 MFI was maintained at a high level. The PMAP-1 MFI was 
significantly positively correlated with CD11b expression, white blood cell counts, neutrophil counts, and C-reactive 
protein levels in patients.
Conclusions: The higher MFIs of PMAP-1 and MitoAP-1 in sepsis patients suggest a pivotal role of ATP for PMN acti-
vation. The temporal difference in ATP levels suggests that ATP plays different roles in the mitochondria and on the 
cell surface. These data should contribute to the understanding of the dynamics of ATP in PMNs and help to develop 
a novel therapy for sepsis.
Keywords: Polymorphonuclear neutrophils (PMNs), PMAP-1, MitoAP-1, Plasma membrane, Mitochondria, Flow 
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Background
ATP is well known as the energy currency of cells and is 
involved in both intracellular signaling and extracellu-
lar signaling. Although polymorphonuclear neutrophils 
(PMNs) are one of the most important phagocytic cell 
types in defending against invading pathogens and play 
a pivotal role in inflammation, their activation can be a 
double-edged sword. In particular, their pathophysiologi-
cal processes can damage the host tissue when activated 
during sepsis, trauma, ischemia–reperfusion injury, and 
inflammatory diseases [1]. PMNs can migrate to com-
promised tissues in response to chemotactic gradients. 
The activation of PMNs is triggered by the recognition 
of bacterial peptides and innate inflammatory media-
tors. Although a signal amplification system is crucial 
for the activation of PMNs, the underlying mechanisms 
remain obscure [2–4]. We previously found that ATP was 
released extracellularly by PMNs through pannexin-1 
(PANX1) hemichannels and that autocrine feedback 
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through the P2Y2 receptor, one of eight P2Y G protein-
coupled receptors, is an essential mechanism for acti-
vating PMNs [5, 6]. We also reported that plasma ATP 
levels were correlated with PMN activation and were 
significantly higher in mouse models of cecal ligation and 
puncture (CLP) [7].
In recent decades, much effort has been dedicated to 
developing fluorescent chemosensors for ATP to study 
its diverse functions [8, 9]. Consequently, two new 
fluorescent chemosensors were developed (PMAP-1 
and MitoAP-1), which can detect ATP and its deriva-
tives in specific regions of living cells [10]. PMAP-1 and 
MitoAP-1 are also referred to as 2-2Zn(ΙΙ) and 3-2Zn(ΙΙ), 
respectively [10]. PMAP-1 can localize to the plasma 
membrane and detect the extracellular release of ATP. 
In contrast, MitoAP-1 can spontaneously localize in the 
mitochondria and detect local ATP.
Sepsis is the major cause of death in critically ill 
patients and is the predominant cause of multiple organ 
dysfunction syndrome [11, 12]. In spite of progress in 
intensive care medicine and strict adherence to estab-
lished treatment protocols such as the “Surviving Sepsis 
Campaign” guidelines [13], mortality in sepsis patients 
remains high. Millions of patients worldwide are afflicted 
each year, resulting in the death of one in three patients 
[11]. Multiple organ failure in sepsis is the prevailing 
cause of death, and mitochondrial dysfunction has been 
suggested to contribute to the development of organ dys-
function and failure in sepsis [14]. However, the associ-
ated pathogenic mechanisms remain unclear.
In this study, we evaluated a new approach to quan-
tify ATP release on the cell surface and ATP produc-
tion in the mitochondria of PMNs by flow cytometry. As 
described above, ATP is known to play a key role in the 
activation of PMNs; thus, we hypothesized that ATP lev-
els on the plasma membrane and in the mitochondria of 
PMNs could serve as an informative biomarker for sepsis. 
Here, we report the correlation between ATP levels and 
the clinical conditions of sepsis patients.
Methods
Patients
After obtaining approval from the ethics committee of 
Juntendo University, Urayasu Hospital (25–47), 16 sep-
sis patients admitted to our critical care center between 
October 2013 and April 2015 were enrolled in the study. 
All patients met the diagnostic criteria for sepsis deter-
mined by the American College of Chest Physicians and 
Society of Critical Care Medicine [15], and all patients (or 
their legal representatives) provided informed consent 
for participation in the research. Patients with malig-
nant disease or chronic administration of steroids were 
excluded. The patients comprised nine males and seven 
females, with a mean ± SD age of 67 ± 9 years, a serum 
C-reactive protein (CRP) level of 27.0  ±  12.1  mg/dL, 
a white blood cell (WBC) count of 13.3 ± 9.1 × 103/μL, 
an Acute Physiology and Chronic Health Evaluation 
(APACHE) II score [16] of 22.1 ± 7.8, a Sequential Organ 
Failure Assessment (SOFA) score [17] of 7.9 ±  4.6, and 
a Japanese Association for Acute Medicine (JAAM) dis-
seminated intravascular coagulation (DIC) score [18] of 
3.8  ±  1.7. The cause of sepsis was urinary tract infec-
tion in five patients; burn in three patients; pneumonia 
in three patients; and necrotic cholecystitis, cellulitis, gas 
gangrene, cervical abscess, and peritonitis in one patient 
each. Two patients died during hospitalization (Table 1). 
The healthy control (HC) group consisted of six males 
and three females, with a mean ± SD age of 37 ± 5 years.
Blood samples
A 10-mL heparinized blood sample was collected via the 
peripheral vein of each healthy volunteer and via arte-
rial lines in sepsis patients. Blood collection for all sep-
sis patients was performed within 24 h after the patients 
were diagnosed with sepsis (days 0–1) and at days 3–4 of 
sepsis.
Isolation of PMNs
Human PMNs were isolated from the heparinized whole 
blood of healthy volunteers and sepsis patients using 
Polymorphprep™ centrifugation (Alere Technologies AS, 
Oslo, Norway). The neutrophil population was >95  % 
pure, as determined by Wright–Giemsa staining.
PMAP‑1 and MitoAP‑1
Both PMAP-1 and MitoAP-1 were designed on the basis 
of a fluorescent ATP probe containing a xanthene fluo-
rophore [10]. PMAP-1 selectively localizes on the plasma 
membrane via a biocompatible anchor for the membrane, 
which possesses a hydrophobic oleyl moiety at the end of 
a long ethylene glycol linker [10]. MitoAP-1 selectively 
localizes to the mitochondria via a positively charged 
pyronin ring [10].
Imaging of PMNs with confocal microscopy
Isolated human PMNs (2.0 ×  106  cells/mL) were plated 
on a 35-mm glass-bottomed dish (IWAKI, Tokyo, 
Japan), coated with 100  μL of poly-l-lysine solution 
(Sigma-Aldrich, St. Louis, MO, USA), and incubated 
for 10  min. All incubations were performed under a 
humidified atmosphere of 5 % CO2 at 37 °C in the dark. 
Cells were treated with 400  nM (final concentration) 
of MitoTracker® Green FM (Invitrogen, Carlsbad, CA, 
USA), followed by incubation with 1 μM MitoAP-1 (final 
concentration) for 20  min. Cells were incubated with 
5  μM PMAP-1 (final concentration) for 10  min. After 
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washing twice with 37  °C Hanks’ balanced salt solution 
(HBSS, Sigma-Aldrich), stained cells were examined with 
a TCS SP5 Leica confocal laser-scanning microscope 
equipped with a Plan-Apochromat 100× oil-immersion 
objective lens at 37  °C, under a 5  % CO2 humidified 
atmosphere.
Fluorescence quantification by flow cytometry
Isolated PMNs were washed with HBSS and incubated 
at 37  °C for 10  min with or without N-formyl-met-leu-
phe (fMLP, ScyTek Laboratories, Logan, UT, USA) stim-
ulation before staining. Cells were incubated with 1 μM 
(final concentration) of MitoAP-1 and allophycocyanin-
conjugated anti-CD11b antibodies (BD Biosciences, San 
Jose, CA, USA) at 37 °C for 20 min, followed by incuba-
tion with 5  μM PMAP-1 (final concentration) at 37  °C 
for 10 min. The cells were placed on ice for 10 min and 
centrifuged at 1500 rpm for 5 min at 4 °C. After washing 
twice with HBSS, cells were fixed with fluorescence-acti-
vated cell sorting (FACS) sheath fluid (BD Biosciences) 
and then analyzed by flow cytometry (FACSCalibur, BD 
Bioscience).
Statistical analysis
The data are expressed as the mean ± SEM unless stated 
otherwise. Statistical analyses were performed using 
GraphPad Prism version 6.0 (GraphPad, San Diego, CA, 
USA). The data were analyzed for significant differences 
by a paired t test or Wilcoxon signed-rank test for com-
parisons of paired groups. One-way analysis of variance 
(ANOVA) and the Kruskal–Wallis test were used for 
comparisons of three groups. Spearman’s rank correla-
tion was performed as indicated. Differences were con-
sidered statistically significant at p < 0.05.
Results
Successful establishment of a staining protocol for human 
PMNs with MitoAP‑1
Imaging studies using PMAP-1 and MitoAP-1 were lim-
ited to cultured cells [10] and T cells [19] until Bao et al. 
[20] first reported imaging studies of human PMNs using 
PMAP-1. As in their study, the bright green fluorescence 
emitted by PMAP-1 was predominantly observed on the 
plasma membrane of PMNs (Fig.  1a). However, there 
has been no previous report of the successful staining of 
human PMNs with MitoAP-1. We observed a punctate 
pattern of bright red fluorescence emitted by MitoAP-1 
within the cells. MitoAP-1 fluorescence overlapped well 
with that of MitoTracker® Green FM, a typical dye used 
to stain the mitochondria, indicating that MitoAP-1 
selectively and spontaneously localized to the mitochon-
dria (Fig. 1b). Thus, we successfully established a method 
for staining human PMNs with MitoAP-1.
ATP release on the plasma membrane of HC PMNs 
increased with fMLP stimulation
Stimulation of the formyl peptide receptor was previ-
ously found to cause ATP release from PMNs through 
maxi-anion channels and PANX1 hemichannels [6]. To 
confirm this finding, the MFI of PMAP-1 on the plasma 
Table 1 Characteristics of sepsis patients
APACHE Acute Physiology and Chronic Health Evaluation, SOFA Sequential Organ Failure Assessment, JAAM Japanese Association for Acute Medicine, DIC 
disseminated intravascular coagulation, WBC white blood cell counts, CRP C-reactive protein, UTI urinary tract infection
Patients Cause of sepsis APACHE ΙΙ score SOFA score JAAM DIC score WBC (/μL) CRP (mg/dL) Mortality
1. Necrotic cholecystitis 31 15 7 4600 27.9 Alive
2. Pneumonia 18 3 4 18,600 48.8 Alive
3. Burn 12 2 2 10,600 23.9 Alive
4. Pneumonia 24 7 3 17,900 35.8 Dead
5. Cellulitis 11 3 3 19,300 54.0 Alive
6. Burn 29 12 4 4100 14.2 Dead
7. UTI 36 14 8 13,900 17.9 Alive
8. UTI 26 11 3 16,400 15.5 Alive
9. UTI 14 6 3 20,700 10.4 Alive
10. Burn 29 13 4 4600 25.5 Alive
11. UTI 20 8 6 31,900 25.8 Alive
12. Gas gangrene 17 2 2 17,100 15.6 Alive
13. Cervical abscess 20 5 3 5000 29.4 Alive
14. UTI 11 4 3 800 29.7 Alive
15. Peritonitis 29 9 3 23,700 21.8 Alive
16. Pneumonia 27 13 3 900 36.0 Alive
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membrane of HC PMNs was quantified by flow cytom-
etry after stimulation with the indicated concentrations of 
fMLP (Fig. 2a). The MFI of PMAP-1 following fMLP stim-
ulation increased in a dose-dependent manner. CD11b 
expression on the plasma membrane of PMNs was also 
measured as a marker of PMN activation. Cell surface 
CD11b expression in PMNs stimulated with fMLP also 
increased in a dose-dependent manner (Fig. 2b).
Mitochondrial ATP levels in the HC group decreased 
with fMLP stimulation
Mitochondria are often referred to as the power-
house of the cells, as they generate ATP by oxidative 
Fig. 1 Confocal micrographs of human polymorphonuclear neutro-
phils (PMNs) stained with PMAP-1 and MitoAP-1. a ATP on the plasma 
membrane was stained with PMAP-1. The bright green fluorescence 
observed on the plasma membrane of PMNs resulted from PMAP-1 
conjugation to ATP (×100 oil objective, NA 1.4). Scale bar 10 μm. 
b ATP in the mitochondria was stained with MitoAP-1 (red) and 
MitoTracker® Green FM (green), and they colocalized well (×100 oil 
objective, NA 1.4). Scale bar 10 μm
Fig. 2 ATP level and CD11b expression after fMLP stimulation 
in healthy control subjects. a Changes in the mean fluorescence 
intensity (MFI) of PMAP-1 after stimulation with the indicated fMLP 
concentrations; MFI values were normalized to those of controls (no 
fMLP) (n = 8 per group). The data shown are the mean ± SEM, and 
groups were compared with one-way ANOVA and Tukey’s post hoc 
test (*p < 0.01). b Changes in CD11b expression of polymorpho-
nuclear neutrophils after fMLP stimulation; expression levels were 
normalized to those of controls (no fMLP) (n = 8 per group). The data 
shown are the mean ± SEM, and groups were compared with one-
way ANOVA with Tukey’s post hoc test (*p < 0.01). c Changes in MFI 
of MitoAP-1 after stimulation with the indicated fMLP concentrations; 
MFI values were normalized to those of controls (no fMLP) (n = 8 
per group). The data shown are the mean ± SEM, and groups were 
compared with one-way ANOVA with Tukey’s post hoc test (*p < 0.01, 
**p < 0.05)
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phosphorylation. To our knowledge, changes in mito-
chondrial ATP levels in PMNs have not been reported. 
The MFI of MitoAP-1 following fMLP stimulation 
decreased significantly in a dose-dependent manner 
(Fig. 2c).
ATP release on the plasma membrane and mitochondrial 
ATP levels in PMNs were higher in sepsis patients than in 
HC subjects
The MFIs of PMAP-1 and MitoAP-1 in sepsis patients 
were evaluated by flow cytometry within 24  h after 
diagnosis of sepsis (days 0–1). Both values were signif-
icantly higher than those of the HC group (Fig.  3a, b). 
CD11b expression on the plasma membrane was also 
upregulated in sepsis patients (Fig. 3c). Activated PMNs 
in sepsis patients appeared to cause a burst of extracel-
lular ATP release and to increase ATP synthesis by oxi-
dative phosphorylation in the mitochondria. The same 
experiments were conducted at days 3–4 as the patients’ 
clinical conditions improved, which revealed that the 
MFIs of PMAP-1 and CD11b expression decreased sig-
nificantly compared to those at days 0–1 (Fig.  3a, c), 
whereas a high MitoAP-1 MFI was maintained (Fig. 3b). 
Namely, the temporal changes of ATP release and 
CD11b expression on the plasma membrane were simi-
lar, but ATP production showed distinct behavior in the 
mitochondria.
ATP release on the plasma membrane correlated with PMN 
activation
As described above, ATP release and CD11b expres-
sion decreased as the clinical conditions of the patients 
improved. Furthermore, the MFIs of PMAP-1 and 
CD11b expression showed a significant positive correla-
tion in the sepsis patients (Fig. 4).
ATP release on the plasma membrane correlated with WBC 
counts, neutrophil counts, and CRP levels
To determine relationships between ATP release on the 
plasma membrane or ATP production in the mitochon-
dria and clinical conditions (WBC counts, neutrophil 
counts, CRP levels, SOFA scores, APACHE II scores, and 
JAAM DIC scores), their correlation coefficients were 
investigated. The MFI of PMAP-1 was significantly posi-
tively correlated with WBC counts, neutrophil counts, 
and CRP levels (Fig.  5), but not with SOFA scores, 
APACHE II scores, and JAAM DIC scores. No correla-
tion was found between the MFI of MitoAP-1 of PMNs 
and any clinical variable.
Fig. 3 Mean fluorescent intensity (MFI) of PMAP-1, MitoAP-1, and CD11b 
expression in PMNs in sepsis patients and healthy control (HC) subjects. 
a MFI of PMAP-1 in sepsis patients (days 0–1 postdiagnosis) was signifi-
cantly higher than that of HCs and decreased significantly on days 3–4 
(mean ± SEM, Kruskal–Wallis test with Dunn’s post hoc test, *p < 0.01). 
b The MFI of MitoAP-1 in sepsis patients (days 0–1) was significantly 
higher than that of HCs and did not decrease significantly on days 3–4 
(mean ± SEM, Kruskal–Wallis test with Dunn’s post hoc test, *p < 0.01). c 
CD11b expression in sepsis patients (days 0–1) was significantly higher 
than that of HCs and decreased significantly on days 3–4 (mean ± SEM, 
one-way ANOVA with Tukey’s post hoc test, *p < 0.01, **p < 0.05)
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Discussion
To our knowledge, this is the first report of the visualiza-
tion of mitochondrial ATP in the PMNs of sepsis patients 
with fluorescent chemosensors. PMNs are the major leu-
kocytes recruited to inflamed sites in response to infec-
tion. Although PMNs play a central role in protecting 
the host from infection, their pathophysiological pro-
cesses can also cause tissue damage in the host [1, 21]. To 
develop therapies that can reduce PMN-induced tissue 
damage, it is crucial to elucidate the mechanisms under-
lying the activation of PMNs.
ATP, which is well known as the “molecular unit of 
currency” of intracellular energy transfer, is released 
extracellularly by physiological stimulation and acts as 
a signaling molecule. Burnstock et al. [22] first reported 
that healthy neurons can release cellular ATP, which 
then serves as an intercellular messenger. Recently, neu-
rons and many other types of cells have been shown to 
release ATP under physiological stimulation, including 
PMNs [23–33]. Previously, we showed that ATP release 
and purinergic signaling are essential for PMN activa-
tion. Extracellular ATP is released by PANX1 hemichan-
nels and controls the chemotaxis of PMNs through P2Y2 
receptors [5, 6]. The autocrine feedback through P2Y2 
receptors is essential for PMN activation [6].
Substantial effort has been dedicated to developing 
fluorescent chemosensors for ATP to elucidate its diverse 
physiological functions [8–10, 34, 35]. To date, a few 
imaging studies using genetically encoded fluorescence 
ATP probes have been reported for this purpose [34, 35]. 
These probes are posttranslationally conjugated to a pro-
tein anchored to a certain organelle through genetically 
encoded localization signals. Although successful, these 
techniques are not convenient, because they require 
cumbersome and time-consuming processes for protein 
expression and maturation. Therefore, Kurishita et  al. 
[10] developed two new types of fluorescent chemosen-
sors, PMAP-1 and MitoAP-1, which can spontaneously 
and selectively localize in a specific cellular region [10]. 
Fig. 4 Correlation between the mean fluorescent intensity (MFI) of 
PMAP-1 and polymorphonuclear neutrophil (PMN) activation (CD11b 
expression). Comparison of PMAP-1 and CD11b expression on the 
plasma membrane showed a significant positive correlation in sepsis 
patients (n = 16, Spearman’s rank correlation coefficient, p < 0.05). 
The 32 data points shown consist of samples from both days 0–1 and 
days 3–4 following sepsis diagnosis
Fig. 5 Correlation of PMAP-1 MFI with white blood cell (WBC) 
counts, neutrophil counts, and C-reactive protein (CRP) levels in 
sepsis patients. a, b Spearman’s rank correlation coefficient, p < 0.01 
(n = 14). Two patients with leukopenia were excluded. The 28 data 
points shown consist of samples from both days 0–1 and days 3–4 
following sepsis diagnosis. c Spearman’s rank correlation coefficient, 
p < 0.01 (n = 16). The 32 data points shown consist of samples from 
both days 0–1 and days 3–4 of sepsis
Page 7 of 8Sueyoshi et al. Ann. Intensive Care  (2016) 6:64 
For example, PMAP-1 localizes to the plasma membrane 
and can be used to detect the extracellular release of ATP, 
whereas MitoAP-1 localizes to the mitochondria and 
senses mitochondrial ATP. Thus, these fluorescent che-
mosensors are highly suited for investigating the dynam-
ics of ATP in biological events occurring in target cellular 
regions [10].
The finding that cell surface ATP release and CD11b 
expression in the HC group increased dose-dependently 
following fMLP stimulation is consistent with our previ-
ous finding that ATP is released by fMLP stimulation via 
PANX1 hemichannels [6]. In sepsis patients, extracellu-
lar ATP release in PMNs was elevated on days 0–1, cor-
roborating our previous work in mouse sepsis models, 
wherein plasma ATP levels were elevated and contrib-
uted to PMN activation [7]. Collectively, these findings 
indicate that PMNs may be a main source of elevated 
circulating ATP levels. Furthermore, ATP release on the 
plasma membrane was correlated with CD11b expres-
sion, WBC counts, neutrophil counts, and CRP levels in 
sepsis patients; thus, ATP release on the plasma mem-
brane may reflect PMN activation and could potentially 
serve as an activation marker for sepsis. Given that 
excessive activation of PMNs can damage host organs, 
inhibition of purinergic signaling could serve as a poten-
tial therapeutic strategy for treating sepsis. Previously, 
we reported that the P2 receptor antagonist suramin 
reduced PMN activation in a mouse CLP model [7]. 
Thus, suramin may potentially be used as an effective 
therapeutic strategy for sepsis patients. In contrast to 
the complications mediated by an overactive neutrophil 
compartment, severe systemic inflammation is a risk 
factor for the development of immune suppression. The 
circulating neutrophil pool displays a paradoxical pheno-
type, exhibiting characteristics of both activated and sup-
pressed functionality. Therefore, further investigations 
are required to resolve this paradox of the role of PMNs 
in sepsis [36].
Mitochondria play an essential role in the activation 
of PMNs by producing ATP, which triggers the puriner-
gic signaling processes [20]. During this process, mito-
chondria generate ATP and release ATP extracellularly 
following fMLP stimulation. However, in the HC group, 
the mitochondrial ATP levels in PMNs decreased with 
fMLP stimulation in a dose-dependent manner, demon-
strating that the mitochondrial ATP was consumed in 
this process in healthy PMNs. Mitochondrial ATP levels 
in PMNs from sepsis patients were significantly higher 
than those of the HC group. Although further investi-
gations are required to determine the definite cause for 
this difference, it is intriguing to speculate that path-
ways other than fMLP stimulation may be essential for 
ATP elevation in the mitochondria. Evaluation of mito-
chondrial function in various cells has been previously 
reported in the context of sepsis [37, 38]. For example, 
Adrie et  al. [37] demonstrated reduced mitochondrial 
membrane potential in peripheral blood monocytes from 
patients with severe sepsis. On the other hand, Belikova 
et  al. [38] showed peripheral blood mononuclear cells 
from patients with severe sepsis had a significantly higher 
baseline value of oxygen consumption compared with 
healthy volunteer cells. This report supports our study 
that mitochondrial ATP production in PMNs from sep-
sis patients was increased. Therefore, understanding the 
interaction among cells is essential to elucidate the mech-
anism of sepsis. Our method shows potential to clarify 
the mechanism of sepsis from the point of view of mito-
chondrial function.
Furthermore, although the PMAP-1 MFI on days 3–4 
of sepsis decreased in parallel with CD11b downregula-
tion, the MFI of MitoAP-1 did not change. These find-
ings suggest that ATP serves different functions on the 
cell surface and in the mitochondria of PMNs in sepsis 
patients.
Conclusions
In conclusion, we developed a novel approach for quan-
tifying ATP release on the cell surface and mitochondrial 
ATP production in PMNs with two new types of fluo-
rescent chemosensors, which was applied to the study 
of sepsis patients. ATP release on the plasma membrane 
of PMNs was demonstrated to be a potentially valuable 
biomarker for sepsis. Taken together with our previous 
studies, our current findings suggest that PMN responses 
can be regulated by therapeutic strategies that target the 
purinergic signaling mechanisms of PMNs. Additional 
studies are needed to determine whether and how these 
purinergic signaling mechanisms can be targeted in order 
to best benefit sepsis patients.
Abbreviations
ANOVA: analysis of variance; APACHE: Acute Physiology and Chronic Health 
Evaluation; CLP: cecal ligation and puncture; CRP: C-reactive protein; DIC: 
disseminated intravascular coagulation; FACS: fluorescence-activated cell 
sorting; fMLP: N-formyl-met-leu-phe; HBSS: Hanks’ balanced salt solution; HC: 
healthy controls; JAAM: Japanese Association for Acute Medicine; MFI: mean 
fluorescence intensity; PMN: polymorphonuclear neutrophil; SOFA: Sequential 
Organ Failure Assessment; WBC: white blood cell.
Authors’ contributions
KS and YS designed and performed the experiments. KS and YS analyzed the 
data and prepared the manuscript. YK performed the experiments with FACS. 
KI supervised and carried out the experiments with confocal microscopy. HN 
and KI supervised the isolation of PMNs. YK, HS, and IH synthesized PMAP-1 
and MitoAP-1 and supervised the usage of PMAP-1 and MitoAP-1. YI and 
HT conceived the idea, reviewed the manuscript, and supervised the whole 
project. All authors read and approved the final manuscript.
Page 8 of 8Sueyoshi et al. Ann. Intensive Care  (2016) 6:64 
Author details
1 Department of Emergency and Critical Care Medicine, Juntendo University, 
Urayasu Hospital, 2-1-1 Tomioka, Urayasu, Chiba 279-0021, Japan. 2 Lipid 
Biology Laboratory, Riken Advanced Science Institute, Wako, Saitama, Japan. 
3 Institute for Environmental and Gender Specific Medicine, Juntendo Univer-
sity, Urayasu, Chiba, Japan. 4 Department of Synthetic Chemistry and Biologi-
cal Chemistry, Graduate School of Engineering, Kyoto University, Kyoto, Japan. 
Acknowledgements
This study was supported in part by the Japan Society for the Promotion of 
Science (23792086, 25462830, to Y.S.), a Grant-in-Aid (S1311011) from the 
Foundation of Strategic Research Projects in Private Universities from the Min-
istry of Education, Culture, Sports, Science, and Technology (MEXT), Japan (to 
K.S.), and Juntendo University Young Investigator Award 2013 (K1310, to K.S).
Competing interests
The authors declare that they have no competing interests.
Received: 17 December 2015   Accepted: 7 July 2016
References
 1. Nussler AK, Wittel UA, Nussler NC, Beger HG. Leukocytes, the Janus cells in 
inflammatory disease. Langenbecks Arch Surg. 1999;384:222–32.
 2. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, 
et al. Cell migration: integrating signals from front to back. Science. 
2003;302:1704–9.
 3. Van Haastert PJ, Devreotes PN. Chemotaxis: signalling the way forward. 
Nat Rev Mol Cell Biol. 2004;5:626–34.
 4. Zigmond SH. Ability of polymorphonuclear leukocytes to orient in gradi-
ents of chemotactic factors. J Cell Biol. 1977;75:606–16.
 5. Chen Y, Corriden R, Inoue Y, Yip L, Hashiguchi N, Zinkernagel A, et al. ATP 
release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science. 
2006;314:1792–5.
 6. Chen Y, Yao Y, Sumi Y, Li A, To UK, Elkhal A, et al. Purinergic signaling: a 
fundamental mechanism in neutrophil activation. Sci Signal. 2010;3:ra45.
 7. Sumi Y, Woehrle T, Chen Y, Bao Y, Li X, Yao Y, et al. Plasma ATP is required 
for neutrophil activation in a mouse sepsis model. Shock. 2014;42:142–7.
 8. Ojida A, Takashima I, Kohira T, Nonaka H, Hamachi I. Turn-on fluorescence 
sensing of nucleoside polyphosphates using a xanthene-based Zn(II) 
complex chemosensor. J Am Chem Soc. 2008;130:12095–101.
 9. Kurishita Y, Kohira T, Ojida A, Hamachi I. Rational design of FRET-based 
ratiometric chemosensors for in vitro and in cell fluorescence analyses of 
nucleoside polyphosphates. J Am Chem Soc. 2010;132:13290–9.
 10. Kurishita Y, Kohira T, Ojida A, Hamachi I. Organelle-localizable 
fluorescent chemosensors for site-specific multicolor imaging of 
nucleoside polyphosphate dynamics in living cells. J Am Chem Soc. 
2012;134:18779–89.
 11. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 
2013;369:840–51.
 12. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl 
J Med. 2003;348:138–50.
 13. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. 
Surviving sepsis campaign: international guidelines for management of 
severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580–637.
 14. Jeger V, Djafarzadeh S, Jakob SM, Takala J. Mitochondrial function in 
sepsis. Eur J Clin Invest. 2013;43:532–42.
 15. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 
SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. 
Crit Care Med. 2003;31:1250–6.
 16. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of 
disease classification system. Crit Care Med. 1985;13:818–29.
 17. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, On 
behalf of the Working Group on Sepsis-Related Problems of the European 
Society of Intensive Care Medicine, et al. The SOFA (Sepsis-related Organ 
Failure Assessment) score to describe organ dysfunction/failure. Intensive 
Care Med. 1996;22:707–10.
 18. Gando S, Iba T, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, et al. A multi-
center, prospective validation of disseminated intravascular coagulation 
diagnostic criteria for critically ill patients: comparing current criteria. Crit 
Care Med. 2006;34:625–31.
 19. Ledderose C, Bao Y, Lidicky M, Zipperle J, Li L, Strasser K, et al. Mitochon-
dria are gate-keepers of T cell function by producing the ATP that drives 
purinergic signaling. J Biol Chem. 2014;289:25936–45.
 20. Bao Y, Ledderose C, Seier T, Graf AF, Brix B, Chong E, et al. Mitochondria 
regulate neutrophil activation by generating ATP for autocrine purinergic 
signaling. J Biol Chem. 2014;289:26794–803.
 21. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med. 
1989;320:365–76.
 22. Burnstock G. Historical review: ATP as a neurotransmitter. Trends Pharma-
col Sci. 2006;27:166–76.
 23. Bodin P, Burnstock G. Evidence that release of adenosine triphosphate 
from endothelial cells during increased shear stress is vesicular. J Cardio-
vasc Pharmacol. 2001;38:900–8.
 24. Buxton IL, Kaiser RA, Oxhorn BC, Cheek DJ. Evidence supporting the 
Nucleotide Axis Hypothesis: ATP release and metabolism by coronary 
endothelium. Am J Physiol Heart Circ Physiol. 2001;281:H1657–66.
 25. Eltzschig HK, Eckle T, Mager A, Kuper N, Karcher C, Weissmuller T, et al. ATP 
release from activated neutrophils occurs via connexin 43 and modulates 
adenosine-dependent endothelial cell function. Circ Res. 2006;99:1100–8.
 26. Fabre AC, Vantourout P, Champagne E, Terce F, Rolland C, Perret B, et al. 
Cell surface adenylate kinase activity regulates the F(1)-ATPase/P2Y 
(13)-mediated HDL endocytosis pathway on human hepatocytes. Cell 
Mol Life Sci. 2006;63:2829–37.
 27. Gerasimovskaya EV, Ahmad S, White CW, Jones PL, Carpenter TC, Sten-
mark KR. Extracellular ATP is an autocrine/paracrine regulator of hypoxia-
induced adventitial fibroblast growth. Signaling through extracellular 
signal-regulated kinase-1/2 and the Egr-1 transcription factor. J Biol 
Chem. 2002;277:44638–50.
 28. Homolya L, Steinberg TH, Boucher RC. Cell to cell communication in 
response to mechanical stress via bilateral release of ATP and UTP in 
polarized epithelia. J Cell Biol. 2000;150:1349–60.
 29. Roman RM, Fitz JG. Emerging roles of purinergic signaling in gastrointes-
tinal epithelial secretion and hepatobiliary function. Gastroenterology. 
1999;116:964–79.
 30. Schwiebert EM, Zsembery A. Extracellular ATP as a signaling molecule for 
epithelial cells. Biochim Biophys Acta. 2003;1615:7–32.
 31. Sorensen CE, Novak I. Visualization of ATP release in pancreatic acini in 
response to cholinergic stimulus. Use of fluorescent probes and confocal 
microscopy. J Biol Chem. 2001;276:32925–32.
 32. Sprague RS, Stephenson AH, Ellsworth ML. Red not dead: signaling in and 
from erythrocytes. Trends Endocrinol Metab. 2007;18:350–5.
 33. Yegutkin G, Bodin P, Burnstock G. Effect of shear stress on the release of 
soluble ecto-enzymes ATPase and 5′-nucleotidase along with endoge-
nous ATP from vascular endothelial cells. Br J Pharmacol. 2000;129:921–6.
 34. Berg J, Hung YP, Yellen G. A genetically encoded fluorescent reporter of 
ATP:ADP ratio. Nat Methods. 2009;6:161–6.
 35. Imamura H, Nhat KP, Togawa H, Saito K, Iino R, Kato-Yamada Y, et al. 
Visualization of ATP levels inside single living cells with fluorescence 
resonance energy transfer-based genetically encoded indicators. Proc 
Natl Acad Sci USA. 2009;106:15651–6.
 36. Pillay J, Ramakers BP, Kamp VM, Loi AL, Lam SW, Hietbrink F, et al. Func-
tional heterogeneity and differential priming of circulating neutrophils in 
human experimental endotoxemia. J Leukoc Biol. 2010;88:211–20.
 37. Adrie C, Bachelet M, Vayssier-Taussat M, Russo-Marie F, Bouchaert I, 
Adib-Conquy M, et al. Mitochondrial membrane potential and apoptosis 
peripheral blood monocytes in severe human sepsis. Am J Respir Crit 
Care Med. 2001;164:389–95.
 38. Belikova I, Lukaszewicz AC, Faivre V, Damoisel C, Singer M, Payen D. 
Oxygen consumption of human peripheral blood mononuclear cells in 
severe human sepsis. Crit Care Med. 2007;35:2702–8.
